🦊/Lists

Healthtech Investors & VC Firms in Middle East & North Africa

297 firms in this list, with a median first check of $600K. 70 of them lead rounds. Generated from verified public data and updated continuously.

Kennet Partners
LondonSeries B–Late Stage$8.6M – $32.4M
19 people
Rabo Corporate Venturing
UtrechtSeed–Growth$11M – $27M
28 people
ICI
Fort CollinsPre-Seed–Seed
26 people
Forepont Capital Partners
New YorkPre-Seed–Late Stage
26 people
Btomorrow Ventures
LondonSeed–Growth
18 people
PeakBridge VC
UtrechtPre-Seed–Series B
15 people
The Raba Partnership
Cape TownPre-Seed–Series C$50K – $5M
10 people
415 Capital
MunichSeries A–Late Stage$5.4M – $16.2M
15 people
Intrepid Growth Partners
TorontoGrowth
17 people
Fisher Lynch Capital
Burlingame
28 people
Georgian
Toronto, OntarioSeries B–Late Stage$25M – $100M
12 people
Vine Ventures
New YorkPre-Seed–Series B$1M – $10M
10 people
The Rohatyn Group
New YorkGrowth
27 people
SBVA
SeoulSeed–Series C$1.7M – $168M
8 people
Debiopharm Innovation Fund
LausannePre-Seed–Late Stage$1M – $5M
18 people
Planven Entrepreneur Ventures
ZurichSeed–Late Stage$10M – $20M
19 people
H.I.G. HealthBridge Partners
MiamiGrowth$5M – $40M
15 people
Expara
SingaporePre-Seed–Series A$320K – $600K
18 people
VKAV (Verod-Kepple Africa Ventures)
LagosSeed–Growth
16 people
JK&B Capital
ChicagoPre-Seed–Late Stage
10 people
Accelmed Partners
MiamiPre-Seed–Late Stage
10 people
Redesign Health
New YorkSeed–Late Stage
18 people
Kaizen Private Equity
Growth
23 people
Next Billion Capital Partners
Series B–Growth
13 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.